Table 2.
Patients complications up to 30 days after surgery
| Variables | COVID-19 patients (n = 44) |
Symptomatic (n = 26) |
Asymptomatic (n = 18) |
|---|---|---|---|
| Complications | |||
| Pulmonary complications | 11 (25%) | 9 (35%) | 2 (11%) |
| Infectious complications (non-pulmonary) | 4 (9%) | 1 (4%) | 3 (17%) |
| Acute kidney injurya | 8 (18%) | 4 (15%) | 4 (22%) |
| Thromboembolic complications | 2 (5%) | 2 (8%) | 0 (0%) |
| Resource utilization | |||
| New ICU admissions | 12 (27%) | 10 (39%) | 2 (11%) |
| Hospital length of stay | 17 [4, 36] | 22 [6, 40] | 7 [3, 22] |
| Mechanical ventilation free days (at 30 days) | 27.0 (7.4) | 25.0 (9.1) | 29.9 (0.3) |
| Organ dysfunction-free days (at 30 days) | 25.2 (9.3) | 22.2 (11.1) | 29.6 (1.4) |
| Mortality | |||
| 30-day mortality | 7 (15.9%) | 6 (23.1%) | 1 (5.6%) |
| Kaplan-Meir survival probabilityb | 0.84 [0.74, 0.96] | 0.77 [0.62, 0.95] | 0.94 [0.84, 1.00] |
Data is reported as mean (SD), as median [q1, q3] or as number of events (proportion in %)
Abbreviations: ICU Intensive care unit
a No acute kidney injury required renal replacement therapy
b 30-day survival probability from the estimated Kaplan-Meir survival function, expressed with 95% confidence intervals